AC

Altos Capital Partners

North America, California, United States, Los Altos

Description

Altos Capital Partners invests in seed to growth stage in a broad range of sectors including technology, real estate, and energy.

Investor Profile

Altos Capital Partners has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series E (50%)
  • Series D (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Hospital
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Altos Capital Partners frequently co-invest with?

Genomic Health
North America, California, United States, Redwood City
Co-Investments: 2
HC
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Domain Associates
North America, California, United States, San Diego
Co-Investments: 2
V
North America, California, United States, Palo Alto
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
SM
North America, New Jersey, United States, Saddle River
Co-Investments: 1
Pagoda Investment
Asia, Beijing, China, Beijing
Co-Investments: 1
V
North America, California, United States, San Mateo
Co-Investments: 2
Blue Ox Healthcare Partners
North America, New York, United States, New York
Co-Investments: 1
Deerfield Capital Management
North America, Illinois, United States, Rosamond
Co-Investments: 1

What are some of recent deals done by Altos Capital Partners?

Epic Sciences

La Jolla, California, United States

Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.

BiotechnologyHealth CareHealth DiagnosticsHospitalPrecision Medicine
Series ESep 12, 2018
Amount Raised: $52,000,000
Epic Sciences

La Jolla, California, United States

Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.

BiotechnologyHealth CareHealth DiagnosticsHospitalPrecision Medicine
Series DApr 28, 2017
Amount Raised: $40,000,000